» Articles » PMID: 35792998

The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review

Overview
Journal Curr Nutr Rep
Date 2022 Jul 6
PMID 35792998
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: This narrative review aimed to explore the functions of betaine and discuss its role in patients with chronic kidney disease (CKD).

Recent Findings: Some studies on CKD animal models have shown the benefits of betaine supplementation, including decreased kidney damage, antioxidant recovery status, and decreased inflammation. Betaine (N-trimethylglycine) is an N-trimethylated amino acid with an essential regulatory osmotic function. Moreover, it is a methyl donor and has anti-inflammatory and antioxidant properties. Additionally, betaine has positive effects on intestinal health by regulating the osmolality and gut microbiota. Due to these crucial functions, betaine has been studied in several diseases, including CKD, in which betaine plasma levels decline with the progression of the disease. Low betaine levels are linked to increased kidney damage, inflammation, oxidative stress, and intestinal dysbiosis. Furthermore, betaine is considered an essential metabolite for identifying CKD stages.

Citing Articles

Network pharmacology and multi-omics validation of the Jianpi-Yishen formula in the treatment of chronic kidney disease.

Li Y, Luo Y, Hu Y, Li S, Li G, Zhang W Front Immunol. 2025; 15:1512519.

PMID: 39877349 PMC: 11772200. DOI: 10.3389/fimmu.2024.1512519.


Cellular and organismal function of choline metabolism.

Kenny T, Scharenberg S, Abu-Remaileh M, Birsoy K Nat Metab. 2025; 7(1):35-52.

PMID: 39779890 DOI: 10.1038/s42255-024-01203-8.


Intra-organ cell specific mitochondrial quantitative interactomics.

Bakhtina A, Campbell M, Sibley B, Sanchez-Contreras M, Sweetwyne M, Bruce J bioRxiv. 2024; .

PMID: 38915719 PMC: 11195139. DOI: 10.1101/2024.06.10.598354.


Untargeted metabolomics reveal signatures of a healthy lifestyle.

Pathmasiri W, Rushing B, McRitchie S, Choudhari M, Du X, Smirnov A Sci Rep. 2024; 14(1):13630.

PMID: 38871777 PMC: 11176323. DOI: 10.1038/s41598-024-64561-z.


Sex-Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort.

Couch C, Ament Z, Patki A, Kijpaisalratana N, Bhave V, Jones A J Am Heart Assoc. 2024; 13(9):e032643.

PMID: 38686877 PMC: 11179891. DOI: 10.1161/JAHA.123.032643.


References
1.
Kim S, Kim Y . Effects of betaine supplementation on hepatic metabolism of sulfur-containing amino acids in mice. J Hepatol. 2005; 42(6):907-13. DOI: 10.1016/j.jhep.2005.01.017. View

2.
Lever M, Slow S . The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem. 2010; 43(9):732-44. DOI: 10.1016/j.clinbiochem.2010.03.009. View

3.
Pourmehdi A, Sakhaei Z, Alirezaei M, Dezfoulian O . Betaine effects against asthma-induced oxidative stress in the liver and kidney of mice. Mol Biol Rep. 2020; 47(8):5729-5735. DOI: 10.1007/s11033-020-05620-2. View

4.
Ueland P . Choline and betaine in health and disease. J Inherit Metab Dis. 2010; 34(1):3-15. DOI: 10.1007/s10545-010-9088-4. View

5.
Dibaba D, Johnson K, Kucharska-Newton A, Meyer K, Zeisel S, Bidulescu A . The Association of Dietary Choline and Betaine With the Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2020; 43(11):2840-2846. PMC: 7576425. DOI: 10.2337/dc20-0733. View